• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于贝叶斯优化的迭代实验设计加速细胞培养基开发

Accelerating cell culture media development using Bayesian optimization-based iterative experimental design.

作者信息

Narayanan Harini, Hinckley Joshua A, Barry Rachel, Dang Brendan, Wolffe Lenna A, Atari Adel, Tseng Yuen-Yi, Love J Christopher

机构信息

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.

出版信息

Nat Commun. 2025 Jul 1;16(1):6055. doi: 10.1038/s41467-025-61113-5.

DOI:10.1038/s41467-025-61113-5
PMID:40593792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12218302/
Abstract

Optimizing operational conditions for complex biological systems used in life sciences research and biotechnology is an arduous task. Here, we apply a Bayesian Optimization-based iterative framework for experimental design to accelerate cell culture media development for two applications. First, we show that this approach yields new compositions of media with cytokine supplementation to maintain the viability and distribution of human peripheral blood mononuclear cells in the culture. Second, we apply this framework to optimize the production of three recombinant proteins in cultivations of K.phaffii. We identified conditions with improved outcomes for both applications compared to the initial standard media using 3-30 times fewer experiments than that estimated for other methods such as the standard Design of Experiments. Subsequently, we also demonstrated the extensibility of our approach to efficiently account for additional design factors through transfer learning. These examples demonstrate how coupling data collection, modeling, and optimization in this iterative paradigm, while using an exploration-exploitation trade-off in each iteration, can reduce the time and resources for complex optimization tasks such as the one demonstrated here.

摘要

优化生命科学研究和生物技术中使用的复杂生物系统的操作条件是一项艰巨的任务。在此,我们应用基于贝叶斯优化的迭代框架进行实验设计,以加速两种应用的细胞培养基开发。首先,我们表明这种方法产生了添加细胞因子的新培养基成分,以维持培养物中人类外周血单核细胞的活力和分布。其次,我们应用此框架优化法夫酵母培养物中三种重组蛋白的生产。与初始标准培养基相比,我们通过比其他方法(如标准实验设计)估计的实验次数少3至30倍的实验,确定了两种应用中具有更好结果的条件。随后,我们还展示了我们的方法通过迁移学习有效考虑其他设计因素的可扩展性。这些例子表明,在这种迭代范式中耦合数据收集、建模和优化,同时在每次迭代中使用探索-利用权衡,可以减少诸如本文所示的复杂优化任务的时间和资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/46a3f4085c1d/41467_2025_61113_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/81629c1cfb56/41467_2025_61113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/ef39f5c1d92d/41467_2025_61113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/0b58e7a74499/41467_2025_61113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/2308a39fc9d5/41467_2025_61113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/2e94ce177657/41467_2025_61113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/46a3f4085c1d/41467_2025_61113_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/81629c1cfb56/41467_2025_61113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/ef39f5c1d92d/41467_2025_61113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/0b58e7a74499/41467_2025_61113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/2308a39fc9d5/41467_2025_61113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/2e94ce177657/41467_2025_61113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df96/12218302/46a3f4085c1d/41467_2025_61113_Fig6_HTML.jpg

相似文献

1
Accelerating cell culture media development using Bayesian optimization-based iterative experimental design.使用基于贝叶斯优化的迭代实验设计加速细胞培养基开发
Nat Commun. 2025 Jul 1;16(1):6055. doi: 10.1038/s41467-025-61113-5.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
4
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
5
Stigma Management Strategies of Autistic Social Media Users.自闭症社交媒体用户的污名管理策略
Autism Adulthood. 2025 May 28;7(3):273-282. doi: 10.1089/aut.2023.0095. eCollection 2025 Jun.
6
Indoor residual spraying for preventing malaria in communities using insecticide-treated nets.室内残留喷洒用杀虫剂处理过的蚊帐预防疟疾在社区中使用。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD012688. doi: 10.1002/14651858.CD012688.pub3.
7
Topical versus systemic antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素与全身用抗生素对比
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013053. doi: 10.1002/14651858.CD013053.pub3.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Topical antiseptics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗菌剂。
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3.
10
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.

本文引用的文献

1
Bayesian cell therapy process optimization.贝叶斯细胞治疗过程优化。
Biotechnol Bioeng. 2024 May;121(5):1569-1582. doi: 10.1002/bit.28669. Epub 2024 Feb 19.
2
Challenges in developing cell culture media using machine learning.使用机器学习开发细胞培养基面临的挑战。
Biotechnol Adv. 2024 Jan-Feb;70:108293. doi: 10.1016/j.biotechadv.2023.108293. Epub 2023 Nov 19.
3
Multi-objective Bayesian algorithm automatically discovers low-cost high-growth serum-free media for cellular agriculture application.多目标贝叶斯算法自动发现用于细胞农业应用的低成本高增长无血清培养基。
Eng Life Sci. 2023 Jun 28;23(8):e2300005. doi: 10.1002/elsc.202300005. eCollection 2023 Aug.
4
Bayesian Optimization for Design of Multiscale Biological Circuits.贝叶斯优化在多尺度生物电路设计中的应用。
ACS Synth Biol. 2023 Jul 21;12(7):2073-2082. doi: 10.1021/acssynbio.3c00120. Epub 2023 Jun 20.
5
Employing active learning in the optimization of culture medium for mammalian cells.采用主动学习优化哺乳动物细胞的培养基。
NPJ Syst Biol Appl. 2023 May 30;9(1):20. doi: 10.1038/s41540-023-00284-7.
6
A review of algorithmic approaches for cell culture media optimization.细胞培养基优化算法方法综述。
Front Bioeng Biotechnol. 2023 May 11;11:1195294. doi: 10.3389/fbioe.2023.1195294. eCollection 2023.
7
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.新兴的类器官-免疫共培养模型在癌症研究中的应用:从肿瘤免疫学到个体化免疫治疗。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006290.
8
Improving extracellular vesicles production through a Bayesian optimization-based experimental design.通过基于贝叶斯优化的实验设计提高细胞外囊泡产量。
Eur J Pharm Biopharm. 2023 Jan;182:103-114. doi: 10.1016/j.ejpb.2022.12.004. Epub 2022 Dec 13.
9
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.设计能同时激活 T 细胞和自然杀伤细胞的癌症免疫疗法。
Annu Rev Immunol. 2023 Apr 26;41:17-38. doi: 10.1146/annurev-immunol-101921-044122. Epub 2022 Nov 29.
10
Cytokines as an important player in the context of CAR-T cell therapy for cancer: Their role in tumor immunomodulation, manufacture, and clinical implications.细胞因子作为癌症 CAR-T 细胞治疗背景下的重要参与者:它们在肿瘤免疫调节、制造和临床意义中的作用。
Front Immunol. 2022 Sep 12;13:947648. doi: 10.3389/fimmu.2022.947648. eCollection 2022.